curacle co.,ltd. (KOSDAQ:365270)
South Korea · Delayed Price · Currency is KRW 9,380.00
+930.00 (11.01%)
At close: Oct 16, 2026
curacle co.,ltd. Market Cap
curacle co.,ltd. has a market cap or net worth of 207.83 billion as of October 16, 2026. It is the 23,085th most valuable company in the world and the 882nd biggest in South Korea. Its market cap has increased by 44.63% in one year.
Market Cap
207.83B
Enterprise Value
195.98B
Revenue
8.24B
Global Rank
Country Rank
#882 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 22, 2021, curacle co.,ltd.'s market cap has decreased from 409.36B to 207.83B, a decrease of -49.23%. That is a compound annual growth rate of -12.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 207.83B | 38.74% |
| Dec 30, 2025 | 149.80B | 79.35% |
| Dec 30, 2024 | 83.52B | -48.17% |
| Dec 28, 2023 | 161.14B | 2.54% |
| Dec 29, 2022 | 157.15B | -49.31% |
| Dec 30, 2021 | 310.02B | -24.27% |
| Jul 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HansBiomed | 310.90B |
| S.Biomedics | 260.71B |
| Genome & Company | 246.07B |
| IMBiologics | 226.26B |
| IntoCell | 223.68B |
| Kangstem Biotech | 180.40B |
| NIBEC | 171.65B |
| ISU Abxis | 156.98B |